These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36060021)

  • 21. The Value of Shear Wave Elastography in Predicting the Risk of Endometrial Cancer and Atypical Endometrial Hyperplasia.
    Ma H; Yang Z; Wang Y; Song H; Zhang F; Yang L; Yan N; Zhang S; Cai Y; Li J
    J Ultrasound Med; 2021 Nov; 40(11):2441-2448. PubMed ID: 33433027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and Surgical Evaluation of Sentinel Node Biopsy in Patients with Early-Stage Endometrial Cancer and Atypical Hyperplasia.
    Pöschke P; Gass P; Krückel A; Keller K; Erber R; Hartmann A; Beckmann MW; Emons J
    Geburtshilfe Frauenheilkd; 2024 May; 84(5):470-476. PubMed ID: 38817597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [GnRH-a combined fertility-sparing re-treatment in women with endometrial carcinoma or atypical endomertial hyperplasia who failed to oral progestin therapy].
    Chen JY; Cao DY; Zhou HM; Yu M; Yang JX; Wang JH; Zhang Y; Cheng NH; Peng P
    Zhonghua Fu Chan Ke Za Zhi; 2021 Aug; 56(8):561-568. PubMed ID: 34420288
    [No Abstract]   [Full Text] [Related]  

  • 24. End-to-end deep learning method for predicting hormonal treatment response in women with atypical endometrial hyperplasia or endometrial cancer.
    Kahaki S; Hagemann IS; Cha KH; Trindade C; Petrick N; Kostelecky N; Borden LE; Atwi D; Fung KM; Chen W
    J Med Imaging (Bellingham); 2024 Jan; 11(1):017502. PubMed ID: 38370423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of coexisting endometrial carcinoma in case of atypical endometrial hyperplasia diagnosed on total hysteroscopic resection.
    Pivano A; Crochet P; Carcopino X; Cravello L; Boubli L; Agostini A
    Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():210-3. PubMed ID: 27343737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can malignant potential of endometrial polyps be determined by incorporating the endometrial intraepithelial neoplasia (EIN) classification?
    Naaman Y; Diment J; Perlman S; Oustinov N; Vaisbuch E; Ben-Arie A
    Gynecol Oncol; 2015 Feb; 136(2):254-7. PubMed ID: 25524459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Predictive Factors of Response to Treatment in Patients Undergoing Conservative Management of Atypical Endometrial Hyperplasia and Early Endometrial Cancer.
    Raffone A; Travaglino A; Flacco ME; Iasevoli M; Mollo A; Guida M; Insabato L; Di Spiezio Sardo A; Carugno J; Zullo F
    J Adolesc Young Adult Oncol; 2021 Apr; 10(2):193-201. PubMed ID: 32799597
    [No Abstract]   [Full Text] [Related]  

  • 28. Supervised clustering of immunohistochemical markers to distinguish atypical endometrial hyperplasia from grade 1 endometrial cancer.
    Laas E; Ballester M; Cortez A; Gonin J; Daraï E; Graesslin O
    Gynecol Oncol; 2014 May; 133(2):205-10. PubMed ID: 24556060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of endometrial carcinogenesis probability while diagnosed as atypical endometrial hyperplasia: a new risk model based on age, CA199 and CA125 assay.
    Zhou L; Meng Z; Wu Y; Zhu H; Wang X
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():5-9. PubMed ID: 25461342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Novel Risk-Scoring Model for Prediction of Premalignant and Malignant Lesions of Uterine Endometrium Among Symptomatic Premenopausal Women.
    Bagepalli Srinivas S; Kubakaddi SS; Polisetti S; Amber S; Guruvare S; Vaman Pai M
    Int J Womens Health; 2020; 12():883-891. PubMed ID: 33149699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Weight-Loss Interventions and Levonorgestrel Intrauterine System Implantation for Early-Stage Endometrial Cancer and Atypical Endometrial Hyperplasia to Reduce Perioperative Risk of Severely Obese Patients.
    Isono-Taniguchi R; Tsubamoto H; Inoue K; Ueda T; Saeki S; Takimoto Y; Wakimoto Y; Shibahara H
    Gynecol Minim Invasive Ther; 2023; 12(3):175-178. PubMed ID: 37807990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Results of treatment of atypical endometrial hyperplasia].
    Tabakman IuIu; Al-Khalabi A; Vasil'eva IA
    Akush Ginekol (Mosk); 1987 Jul; (7):35-7. PubMed ID: 3688327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of
    Krasnyi AM; Gadzhieva LT; Kokoeva DN; Kosenko MG; Yarotskaya EL; Pavlovich SV; Ashrafyan LA; Sukhikh GT
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Analysis of pregnancy outcome after fertility-preserving treatment among women with atypical endometrial hyperplasia or endometrial carcinoma].
    Xiao ZR; Lu Q; Zhou R; Wang YQ; Liang WY; Liu HX; Tang HR; Wu GZ; Liu XS; Zhang H; Ren Y; Wang JL
    Zhonghua Fu Chan Ke Za Zhi; 2020 Dec; 55(12):857-864. PubMed ID: 33355761
    [No Abstract]   [Full Text] [Related]  

  • 35. Mismatch repair-deficiency specifically predicts recurrence of atypical endometrial hyperplasia and early endometrial carcinoma after conservative treatment: A multi-center study.
    Raffone A; Catena U; Travaglino A; Masciullo V; Spadola S; Della Corte L; Piermattei A; Insabato L; Zannoni GF; Scambia G; Zullo F; Bifulco G; Fanfani F; Di Spiezio Sardo A
    Gynecol Oncol; 2021 Jun; 161(3):795-801. PubMed ID: 33812697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atypical Endometrial Hyperplasia and Concurrent Cancer: A Comprehensive Overview on a Challenging Clinical Condition.
    Giannella L; Grelloni C; Bernardi M; Cicoli C; Lavezzo F; Sartini G; Natalini L; Bordini M; Petrini M; Petrucci J; Terenzi T; Delli Carpini G; Di Giuseppe J; Ciavattini A
    Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of Megestrol for the Treatment of Patients with Atypical Endometrial Hyperplasia or Endometrial Endometrioid Adenocarcinoma (Stage IA, Well Differentiated).
    Akhavan S; Sabet F; Mousavi AS; Gilani MM; Hasani SS
    J Res Pharm Pract; 2021; 10(3):138-143. PubMed ID: 35198507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Role of Magnetic Resonance Imaging in the Pre-operative Evaluation of Women Diagnosed With Atypical Endometrial Hyperplasia.
    Liakou CG; La Russa MC; Akrivos N; Ames V; Scott-Barrett S; Duncan TJ; Nieto JJ; Burbos N
    Anticancer Res; 2020 May; 40(5):2989-2993. PubMed ID: 32366453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hysteroscopic Endometrial Focal Resection followed by Levonorgestrel Intrauterine Device Insertion as a Fertility-Sparing Treatment of Atypical Endometrial Hyperplasia and Early Endometrial Cancer: A Retrospective Study.
    Giampaolino P; Di Spiezio Sardo A; Mollo A; Raffone A; Travaglino A; Boccellino A; Zizolfi B; Insabato L; Zullo F; De Placido G; Bifulco G
    J Minim Invasive Gynecol; 2019; 26(4):648-656. PubMed ID: 30017893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective evaluation of abnormal glucose metabolism and insulin resistance in patients with atypical endometrial hyperplasia and endometrial cancer.
    Mitsuhashi A; Uehara T; Hanawa S; Shozu M
    Support Care Cancer; 2017 May; 25(5):1495-1501. PubMed ID: 28028620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.